India Celiac Disease Treatment Market Overview
As per MRFR analysis, the India Celiac Disease Treatment Market Size was estimated at 27.47 (USD Million) in 2023. The India Celiac Disease Treatment Market Industry is expected to grow from 30.5(USD Million) in 2024 to 380 (USD Million) by 2035. The India Celiac Disease Treatment Market CAGR (growth rate) is expected to be around 25.774% during the forecast period (2025 - 2035)
Key India Celiac Disease Treatment Market Trends Highlighted
The India Celiac Disease Treatment Market is witnessing significant trends driven by the increasing prevalence of celiac disease among the population. Awareness about gluten-related disorders has grown considerably in recent years, leading to more patients seeking diagnosis and treatment options.
This growing awareness is spurred by information campaigns and increased access to healthcare services, aligning with the government's initiatives to improve healthcare access and education across the country.
The rise in gluten-free product availability in supermarkets and niche health stores also reflects changing consumer preferences and dietary habits. Moreover, there are prospects in creating culturally relevant dietary supplements, as well as gluten-free food items, specially designed for Indian consumers with very particular dietary needs. The Indian food industry is beginning to evolve to serve this market, where manufacturers are working on gluten-free grains and health-oriented products, presenting a worthwhile area for investment, innovation, and entrepreneurship.
Also, with the development of the healthcare framework, there is more focus on dietetics and nutritional counseling for patients with celiac disease. For other recent trends, collaboration between healthcare professionals and the food industry to create awareness campaigns and promote gluten-free diets has gained popularity.
The rise of online platforms for purchasing gluten-free products is helping bolster access for consumers throughout India, including rural areas. This shift provides convenience and further educates the population on managing celiac disease through diet, thus improving overall health outcomes and increasing demand in the market. The combination of awareness, evolving consumer needs, and better healthcare access continues to shape the landscape of the celiac disease treatment market in India.

Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
India Celiac Disease Treatment Market Drivers
Rising Prevalence of Celiac Disease in India
The increasing prevalence of Celiac Disease among the Indian population serves as a significant driver for the India Celiac Disease Treatment Market Industry. According to the Indian Society of Gastroenterology, the prevalence rate of Celiac Disease in India is estimated to be around 1 in 100 individuals, which translates to approximately 1.3 crore people affected. This substantial population of individuals requiring diagnosis and treatment intensifies the demand for relevant therapies and interventions.
The robust efforts by organizations such as the All India Institute of Medical Sciences (AIIMS) and various health ministries in enhancing awareness and establishing screening programs contribute significantly to diagnosing undiscovered cases. The more awareness and screening that take place, the larger the audience requiring medical treatment, leading to a sharply defined growth trajectory for the market over the coming years.
Advancements in Medical Technology and Research
The rapid advancements in medical technology and Research and Development (R&D) initiatives are propelling the growth of the India Celiac Disease Treatment Market Industry. Innovative treatment options, such as enzyme-based therapies and gluten-free food products, are emerging as effective alternatives to managing the disease. A report by the Department of Biotechnology under the Government of India highlights a notable increase in funding for R&D projects focused on Celiac Disease, which has more than doubled in the last five years.This investment fosters the development of improved treatments and diagnostic tools that cater to the specific needs of Indian patients. Companies like Dr. Reddy's Laboratories are viewing the realm of Celiac Disease treatment as a priority in their R&D agenda, providing a momentum that is substantial for market growth.
Growing Awareness and Education Campaigns
The growing awareness and education campaigns about Celiac Disease are significantly influencing the India Celiac Disease Treatment Market. Government bodies and non-profit organizations are strategically carrying out awareness programs that emphasize the importance of early diagnosis and management of Celiac Disease.
For instance, initiatives led by the Ministry of Health and Family Welfare promote educational workshops and community health outreach, reaching millions.This has resulted in an uptick in the number of diagnosed cases, as shown in recent surveys, indicating that over 60% of those diagnosed have learned about the disease through these initiatives. The increased visibility of Celiac Disease is creating a heightened demand for treatment options amongst the affected population.
India Celiac Disease Treatment Market Segment Insights
Celiac Disease Treatment Market Treatment Type Insights
The India Celiac Disease Treatment Market demonstrates diverse opportunities through its Treatment Type segment, which is pivotal in addressing the growing awareness and medical management of celiac disease across the nation. Among the various approaches to treatment, the Gluten Free Diet stands out as a cornerstone for managing this autoimmune condition, as it entails a strict avoidance of gluten, thus allowing individuals suffering from celiac disease to lead healthier lives.
Given the cultural significance of food in India and the ubiquity of gluten-containing grains, the emphasis on gluten-free alternatives is increasing, prompting a surge in the availability of gluten-free products. This shift reflects the dietary adjustments needed for patients and responds to the rising consumer demand for healthier and gluten-free food options.
Moreover, Vitamin and Minerals Supplements play a critical role in the management of celiac disease, especially as many patients experience malabsorption due to intestinal damage caused by gluten. These supplements provide essential nutrients that individuals may lack due to restricted diets, thereby promoting better health and well-being. The increasing incidence of nutritional deficiencies among patients, coupled with the heightened awareness around health and nutrition, propels the demand for these supplements in India. Medical Therapies, while still under investigation compared to dietary approaches, are gaining attention as effective adjuncts to treatment.
Ongoing Research and Development in this area aim to create innovative therapies that may offer alternatives or complements to dietary restrictions, enhancing the overall quality of life for patients. The evolving landscape of medical therapies provides a promising avenue for future growth as the healthcare ecosystem in India expands to include more comprehensive treatment options for celiac disease.In summary, the Treatment Type for the India Celiac Disease Treatment Market represents a multifaceted approach combining dietary management, nutritional support, and emerging medical therapies.
The increasing approval of gluten-free food products, the recognition of the importance of nutritional supplementation, and ongoing advances in medical therapies highlight the significant and growing landscape of celiac disease management within India. As market growth accelerates, these components work together to create a more integrated approach to treating celiac disease, ensuring that patients can navigate their dietary limitations while maintaining optimal health. The critical interplay of these elements promises to shape the future of celiac disease treatment in India significantly.

Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
Celiac Disease Treatment Market End User Insights
The India Celiac Disease Treatment Market is experiencing significant growth, particularly in its End User segment, which includes Hospitals and Clinics, Research Centers, and Others. Hospitals and Clinics play a crucial role in providing diagnostic and treatment services for celiac disease, driven by the increasing awareness and diagnosis rates among the population. With government initiatives aimed at improving healthcare infrastructure, there's a growing inclination towards specialized care in these facilities.
Research Centers hold substantial importance as they contribute to the development of innovative treatment options and therapies, which are essential for advancing patient care and understanding of celiac disease.Additionally, the Others category includes community health organizations and support groups, which are vital in raising awareness and providing education on lifestyle management for patients. The combined efforts of these End Users showcase a commitment to enhancing the quality of care, thereby addressing the increasing prevalence of celiac disease in India. The market growth is further bolstered by rising health consciousness and lifestyle changes among the Indian population, presenting ample opportunities for stakeholders within the India Celiac Disease Treatment Market.
India Celiac Disease Treatment Market Key Players and Competitive Insights
The India Celiac Disease Treatment Market is witnessing significant growth as awareness of celiac disease and gluten-free diets increases among the population. This growth is driven by the rising incidence of celiac disease, an autoimmune disorder that impacts individuals' ability to consume gluten. As a result, various companies are entering the market to provide treatments, gluten-free products, and other services tailored for this particular health issue. The competitive landscape is characterized by a mix of established brands and emerging players focusing on innovative solutions, thereby enhancing the treatment options available to consumers.
The increasing number of health-conscious individuals, along with improved diagnostic techniques, is contributing to the expanding market, with companies striving to establish themselves as key players through product differentiation and strategic collaborations.Nature's Path Foods stands out in the India Celiac Disease Treatment Market due to its commitment to organic, non-GMO, and gluten-free food products. The company has successfully built a strong brand reputation among health-conscious consumers looking for safe and nutritious options. With an extensive range of offerings, including cereals, granolas, and snacks aimed explicitly at those with gluten sensitivity, Nature's Path Foods has cemented its position by focusing on quality and sustainable sourcing.
The company's strengths lie in its highly effective marketing strategies that highlight the health benefits of its products, making it a preferred choice for many gluten-free consumers in India. This focus on healthful living aligns well with the increasing demand for gluten-free alternatives in the region, helping Nature's Path Foods to maintain a competitive edge.Kraft Heinz has made an impactful entry into the India Celiac Disease Treatment Market by offering a variety of gluten-free products under some of its well-known brands.
The company has positioned itself effectively by launching products that cater to the need for safe and enjoyable gluten-free alternatives for celiac disease patients. Key offerings include sauces, snacks, and meal solutions that not only comply with gluten-free standards but also appeal to the taste and preferences of Indian consumers.
Kraft Heinz's strengths include its robust distribution network, which ensures product availability across various regions in India. Additionally, the company's commitment to research and development has led to the formulation of innovative gluten-free products that resonate with the local market. Although specific mergers and acquisitions related to the gluten-free sector are less prominent, Kraft Heinz's broad market presence and strategic partnerships enhance its capacity to compete effectively in this evolving market landscape.
Key Companies in the India Celiac Disease Treatment Market Include
- Nature's Path Foods
- Kraft Heinz
- Gluten Free Foods
- Dr. Schär
- Whitewave Foods
- Quinoa Corporation
- Indra Foods
- FritoLay
- Danone
- General Mills
- Nestlé
- Conagra Brands
- Patanjali Ayurved
- Bells of Ireland
- Unilever
India Celiac Disease Treatment Market Industry Developments
Recent developments in the India Celiac Disease Treatment Market show significant advancements and growing consumer awareness. Notably, Nature's Path Foods and General Mills have both expanded their gluten-free product lines, contributing to increased availability of treatment options for celiac disease within India. A heightened focus on health and wellness is driving demand for gluten-free foods, evidenced by an array of new product launches in the market. Current affairs reflect a shift towards more health-conscious dietary choices, prompting major companies like Kraft Heinz and Nestlé to invest in gluten-free solutions tailored for the Indian palate.
In terms of market valuation, the Indian gluten-free food market has shown a compounded annual growth rate, fostering optimism among stakeholders regarding profitability and expansion opportunities. Mergers and acquisitions have been relatively quiet in the last months, but previously, in August 2022, Dr. Schär acquired a regional competitor, further solidifying its position in the Indian market. Additionally, the government supports initiatives promoting celiac disease awareness, thereby enhancing market potential for therapeutic options. The continued evolution of gluten-free products and rising consumer awareness reflect a dynamic landscape focused on health-oriented dietary solutions within India.
India Celiac Disease Treatment Market Segmentation Insights
- Celiac Disease Treatment Market Treatment Type Outlook
- Gluten Free Diet
- Vitamin and Minerals Supplements
- Medical Therapies
- Celiac Disease Treatment Market End User Outlook
- Hospitals and Clinics
- Research Centers
- Others
Report Attribute/Metric Source: |
Details |
MARKET SIZE 2023 |
27.47(USD Million) |
MARKET SIZE 2024 |
30.5(USD Million) |
MARKET SIZE 2035 |
380.0(USD Million) |
COMPOUND ANNUAL GROWTH RATE (CAGR) |
25.774% (2025 - 2035) |
REPORT COVERAGE |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
BASE YEAR |
2024 |
MARKET FORECAST PERIOD |
2025 - 2035 |
HISTORICAL DATA |
2019 - 2024 |
MARKET FORECAST UNITS |
USD Million |
KEY COMPANIES PROFILED |
Nature's Path Foods, Kraft Heinz, Gluten Free Foods, Dr. Schär, Whitewave Foods, Quinoa Corporation, Indra Foods, FritoLay, Danone, General Mills, Nestlé, Conagra Brands, Patanjali Ayurved, Bells of Ireland, Unilever |
SEGMENTS COVERED |
Treatment Type, End User |
KEY MARKET OPPORTUNITIES |
Increased gluten-free product demand, Expanding awareness and diagnosis, Rising healthcare investments, Growth in e-commerce platforms, Supportive government initiatives |
KEY MARKET DYNAMICS |
Increasing prevalence of celiac disease, Growing awareness and diagnosis, Rising demand for gluten-free products, Costly treatment options, Government support for research |
COUNTRIES COVERED |
India |
Frequently Asked Questions (FAQ) :
The India Celiac Disease Treatment Market is expected to be valued at 30.5 million USD in 2024.
By 2035, the India Celiac Disease Treatment Market is projected to reach a value of 380.0 million USD.
The India Celiac Disease Treatment Market is expected to grow at a CAGR of 25.774 percent from 2025 to 2035.
The Gluten Free Diet segment will hold the largest market share, valued at 12.0 million USD in 2024 and projected to reach 150.0 million USD by 2035.
Major players include Nature's Path Foods, Kraft Heinz, Gluten Free Foods, Dr. Schär, and Whitewave Foods among others.
The Vitamin and Minerals Supplements segment is valued at 10.5 million USD in 2024 and is projected to grow to 130.0 million USD by 2035.
The Medical Therapies segment is expected to be valued at 8.0 million USD in the India Celiac Disease Treatment Market by 2024.
The market presents opportunities driven by rising awareness of celiac disease and increasing demand for gluten-free products.
The market is experiencing trends such as increased adoption of gluten-free diets and a rise in the development of medical therapies.
Challenges include limited awareness about celiac disease among the population and potential cost barriers for gluten-free products.